Prostate Cancer | Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer
Research To Practice | Oncology Videos · Dr. Neil Love
August 14, 20232h 48m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Dr Neeraj Agarwal, Dr Emmanuel S Antonarakis, Prof Karim Fizazi and Dr Susan F Slovin, including the following topics:
- Introduction: Current landscape of prostate cancer treatment (0:00)
- Relevance of homologous recombination repair mutations in castration-resistant prostate cancer: Treatment with PARP inhibitors as monotherapy — Dr Antonarakis (12:33)
- Phase III PROpel and MAGNITUDE trials — Dr Slovin (35:44)
- PARP inhibitor combination treatments for advanced prostate cancer — Dr Agarwal (57:08)
- Future directions in the use of PARP inhibitors for prostate cancer — Prof Fizazi (1:23:49)
- Journal Club (1:35:53)
- Case discussions (2:11:57)